Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 3
2012 3
2013 3
2014 2
2015 4
2017 1
2018 1
2019 2
2020 2
2021 7
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean brock s[au] (189 results)?
Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal versus nasopharyngeal swab.
Lindner AK, Nikolai O, Rohardt C, Burock S, Hülso C, Bölke A, Gertler M, Krüger LJ, Gaeddert M, Tobian F, Lainati F, Seybold J, Jones TC, Hofmann J, Sacks JA, Mockenhaupt FP, Denkinger CM. Lindner AK, et al. Among authors: burock s. Eur Respir J. 2021 May 6;57(5):2004430. doi: 10.1183/13993003.04430-2020. Print 2021 May. Eur Respir J. 2021. PMID: 33574072 Free PMC article.
Building a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: A prospective liver metastasis database with an integrated quality assurance program.
Caballero C, Burock S, Carrion-Alvarez L, Nilsson H, Ruers T, Senellart P, Rivoire M, Stattner S, Primavesi F, Troisi R, Gruenberger T, Heil J, Schnitzbauer AA, Rahbari NN, Swijnenburg RJ, Malik H, Protic M, Kataoka K, Mauer M, Ducreux M, Poston G, Evrard S. Caballero C, et al. Among authors: burock s. Eur J Surg Oncol. 2019 Oct;45(10):1870-1875. doi: 10.1016/j.ejso.2019.05.028. Epub 2019 May 30. Eur J Surg Oncol. 2019. PMID: 31171479 Review.
Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test.
Lindner AK, Nikolai O, Rohardt C, Kausch F, Wintel M, Gertler M, Burock S, Hörig M, Bernhard J, Tobian F, Gaeddert M, Lainati F, Corman VM, Jones TC, Sacks JA, Seybold J, Denkinger CM, Mockenhaupt FP. Lindner AK, et al. Among authors: burock s. J Clin Virol. 2021 Aug;141:104874. doi: 10.1016/j.jcv.2021.104874. Epub 2021 May 29. J Clin Virol. 2021. PMID: 34144452 Free PMC article.
SARS-CoV-2 Variant of Concern B.1.1.7: Diagnostic Sensitivity of Three Antigen-Detecting Rapid Tests.
Lindner AK, Krüger LJ, Nikolai O, Klein JAF, Rössig H, Schnitzler P, Corman VM, Jones TC, Tobian F, Gaeddert M, Burock S, Sacks JA, Seybold J, Mockenhaupt FP, Denkinger CM. Lindner AK, et al. Among authors: burock s. Microbiol Spectr. 2022 Feb 23;10(1):e0076321. doi: 10.1128/spectrum.00763-21. Epub 2022 Jan 5. Microbiol Spectr. 2022. PMID: 34985330 Free PMC article. No abstract available.
The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis.
Kobelt D, Perez-Hernandez D, Fleuter C, Dahlmann M, Zincke F, Smith J, Migotti R, Popp O, Burock S, Walther W, Dittmar G, Mertins P, Stein U. Kobelt D, et al. Among authors: burock s. Oncogene. 2021 Aug;40(34):5286-5301. doi: 10.1038/s41388-021-01917-z. Epub 2021 Jul 10. Oncogene. 2021. PMID: 34247190 Free PMC article.
Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study.
Leyvraz S, Konietschke F, Peuker C, Schütte M, Kessler T, Ochsenreither S, Ditzhaus M, Sprünken ED, Dörpholz G, Lamping M, Rieke DT, Klinghammer K, Burock S, Ulrich C, Poch G, Schäfer R, Klauschen F, Joussen A, Yaspo ML, Keilholz U. Leyvraz S, et al. Among authors: burock s. Eur J Cancer. 2022 Jul;169:146-155. doi: 10.1016/j.ejca.2022.04.004. Epub 2022 May 12. Eur J Cancer. 2022. PMID: 35569281
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis).
Beck M, Ghadjar P, Mehrhof F, Zips D, Paulsen F, Wegener D, Burock S, Kaul D, Stromberger C, Nadobny J, Ott OJ, Fietkau R, Budach V, Wust P, Müller AC, Zschaeck S. Beck M, et al. Among authors: burock s. Cancers (Basel). 2021 Mar 6;13(5):1133. doi: 10.3390/cancers13051133. Cancers (Basel). 2021. PMID: 33800872 Free PMC article.
Support of a molecular tumour board by an evidence-based decision management system for precision oncology.
Lamping M, Benary M, Leyvraz S, Messerschmidt C, Blanc E, Kessler T, Schütte M, Lenze D, Jöhrens K, Burock S, Klinghammer K, Ochsenreither S, Sers C, Schäfer R, Tinhofer I, Beule D, Klauschen F, Yaspo ML, Keilholz U, Rieke DT. Lamping M, et al. Among authors: burock s. Eur J Cancer. 2020 Mar;127:41-51. doi: 10.1016/j.ejca.2019.12.017. Epub 2020 Jan 23. Eur J Cancer. 2020. PMID: 31982633
33 results